Introduction of Group Electronic Monitoring of Hand Hygiene on Inpatient Units: A Multicenter Cluster Randomized Quality Improvement Study.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 07 01 2020
accepted: 08 04 2020
pubmed: 10 4 2020
medline: 29 4 2021
entrez: 10 4 2020
Statut: ppublish

Résumé

The current approach to measuring hand hygiene (HH) relies on human auditors who capture <1% of HH opportunities and rapidly become recognized by staff, resulting in inflation in performance. Group electronic monitoring is a validated method of measuring HH adherence, but data demonstrating the clinical impact of this technology are lacking. A stepped-wedge cluster randomized quality improvement study was performed on 26 inpatient medical and surgical units across 5 acute care hospitals in Ontario, Canada. The intervention involved daily HH reporting as measured by group electronic monitoring to guide unit-led improvement strategies. The primary outcome was monthly HH adherence (percentage) between baseline and intervention. Secondary outcomes included transmission of antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections. After adjusting for the correlation within inpatient units and hospitals, there was a significant overall improvement in HH adherence associated with the intervention (incidence rate ratio [IRR], 1.73 [95% confidence interval {CI}, 1.47-1.99]; P < .0001). Monthly HH adherence relative to the intervention increased from 29% (1 395 450/4 544 144) to 37% (598 035/1 536 643) within 1 month, followed by consecutive incremental increases up to 53% (804 108/1 515 537) by 10 months (P < .0001). There was a trend toward reduced healthcare-associated transmission of MRSA (IRR, 0.74 [95% CI, .53-1.04]; P = .08). The introduction of a system for group electronic monitoring led to rapid, significant improvements in HH performance within a 2-year period. This method offers significant advantages over direct observation for measurement and improvement of HH.

Sections du résumé

BACKGROUND
The current approach to measuring hand hygiene (HH) relies on human auditors who capture <1% of HH opportunities and rapidly become recognized by staff, resulting in inflation in performance. Group electronic monitoring is a validated method of measuring HH adherence, but data demonstrating the clinical impact of this technology are lacking.
METHODS
A stepped-wedge cluster randomized quality improvement study was performed on 26 inpatient medical and surgical units across 5 acute care hospitals in Ontario, Canada. The intervention involved daily HH reporting as measured by group electronic monitoring to guide unit-led improvement strategies. The primary outcome was monthly HH adherence (percentage) between baseline and intervention. Secondary outcomes included transmission of antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections.
RESULTS
After adjusting for the correlation within inpatient units and hospitals, there was a significant overall improvement in HH adherence associated with the intervention (incidence rate ratio [IRR], 1.73 [95% confidence interval {CI}, 1.47-1.99]; P < .0001). Monthly HH adherence relative to the intervention increased from 29% (1 395 450/4 544 144) to 37% (598 035/1 536 643) within 1 month, followed by consecutive incremental increases up to 53% (804 108/1 515 537) by 10 months (P < .0001). There was a trend toward reduced healthcare-associated transmission of MRSA (IRR, 0.74 [95% CI, .53-1.04]; P = .08).
CONCLUSIONS
The introduction of a system for group electronic monitoring led to rapid, significant improvements in HH performance within a 2-year period. This method offers significant advantages over direct observation for measurement and improvement of HH.

Identifiants

pubmed: 32270865
pii: 5818269
doi: 10.1093/cid/ciaa412
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e680-e685

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Jerome A Leis (JA)

Sunnybrook Health Sciences Centre, Toronto, Canada.
Sunnybrook Research Institute, Toronto, Canada.
Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Canada.
Centre for Quality Improvement and Patient Safety, University of Toronto, Toronto, Canada.

Jeff E Powis (JE)

Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Canada.
Centre for Quality Improvement and Patient Safety, University of Toronto, Toronto, Canada.
Michael Garron Hospital, Toronto, Canada.

Allison McGeer (A)

Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Canada.
Sinai Health Systems, Toronto, Canada.

Daniel R Ricciuto (DR)

Lakeridge Health, Oshawa, Canada.

Tanya Agnihotri (T)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Natalie Coyle (N)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Victoria Williams (V)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Christine Moore (C)

Sinai Health Systems, Toronto, Canada.

Natasha Salt (N)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Louis Wong (L)

Sinai Health Systems, Toronto, Canada.

Liz McCreight (L)

Sinai Health Systems, Toronto, Canada.

Sajeetha Sivaramakrishna (S)

Michael Garron Hospital, Toronto, Canada.

Shara Junaid (S)

St Michael's Hospital, Toronto, Canada.

Xinghan Cao (X)

Sunnybrook Research Institute, Toronto, Canada.

Matthew Muller (M)

Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Canada.
St Michael's Hospital, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH